The Orgreave Inquiry opened its Call for Evidence on 26 March 2026, which signified the start of Phase One of the Inquiry.
The Inquiry’s Information Booklet was sent to the constituency office of all 650 Members of Parliament and over 3,500 copies have been circulated around the UK, including at the Orgreave Anniversary March and Rally on 13 June 2026.
By 3 July 2026, the Inquiry had received over 100 responses, varying in length, format, and the issues covered. These included video clips, voice recordings, legal documents, photographs, newspaper articles, and published academic material.
The responses ranged from declarations of interest in engagement to firsthand accounts of events at Orgreave on 18 June 1984. They also included descriptions of the personal impact of events on family and local community.
This material, taken together with stakeholder engagement, has identified a further 118 Persons of Interest who will be contacted as the Inquiry moves forward.
The emerging themes from these initial responses informed the Inquiry’s Provisional List of Issues, published on 3 July 2026, which marked the end of Phase One.
The List of Issues will remain in a provisional state as it may evolve throughout the Inquiry’s life.
We recognise that coming forward can feel difficult, and the Call for Evidence remains open to ensure people have the opportunity to share experiences and information when they are ready. Any evidence submitted to the Inquiry will be treated with care, respect, and sensitivity, and will help to inform the Inquiry’s work.
A summary for this phase will be added at the end of Phase 2.
A summary for this phase will be added at the end of Phase 3 .
A summary for this phase will be added at the end of Phase 4.
A summary for this phase will be added at the end of Phase 5.
A summary for this phase will be added at the end of Phase 6.
A summary for this phase will be added at the end of Phase 7.
A summary for this phase will be added at the end of Phase 8.
A summary for this phase will be added at the end of Phase 9.
